Never combine tesofensine with MAO inhibitors, SSRIs, SNRIs, or any stimulant peptides containing DMAA, ephedrine, or synephrine
Acknowledgements The authors thank Prof
In a randomized clinical trial, weekly oral vitamin D supplementation during neoadjuvant systemic therapy significantly improved pathologic complete response rates in breast cancer patients, particularly in those with hormone receptornegative tumors and high Ki67 expression
We chose a fixed-effects model when heterogeneity was low
Medication Effects: SGLT2 inhibitors (such as empagliflozin, dapagliflozin, canagliflozin) commonly cause increased urination and genital/urinary tract infections as direct pharmacological effects
For foundational longevity context, see AgeMD Longevity Medicine